Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer Who Have Received Two or Three Prior Systemic Chemotherapy Regimens

Next Previous
X
Search
Trial Profile

A Phase 2 Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer Who Have Received Two or Three Prior Systemic Chemotherapy Regimens

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Aug 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CTX 009 (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms COMPANION-003
  • Sponsors Compass Therapeutics

    • Most Recent Events

    • 12 Aug 2024 Preliminary results for 41 patients (as of August 6, 2024) from Stage 1 of this study, presented in Compass Therapeutics media release.
    • 12 Aug 2024 According to a Compass Therapeutics media release, the company has completed the review of encouraging preliminary data from Stage 1 of this study. Based on this data, study designs for another Phase 2 trial are evaluated, to study CTX-009 in combination with chemotherapy in the second-line setting. Stage 2 of this trial will not be continued.
    • 01 Apr 2024 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top